UBS Group’s 89bio ETNB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-666,842
| Closed | -$9.8M | – | 10679 |
|
|
2025
Q3 | $9.8M | Buy |
666,842
+317,397
| +91% | +$3.24M | ﹤0.01% | 3310 |
|
|
2025
Q2 | $3.43M | Buy |
349,445
+146,238
| +72% | +$1.21M | ﹤0.01% | 4261 |
|
|
2025
Q1 | $1.48M | Buy |
203,207
+90,022
| +80% | +$787K | ﹤0.01% | 4953 |
|
|
2024
Q4 | $885K | Sell |
113,185
-128,319
| -53% | -$1.06M | ﹤0.01% | 5403 |
|
|
2024
Q3 | $1.79M | Buy |
241,504
+115,448
| +92% | +$971K | ﹤0.01% | 4110 |
|
|
2024
Q2 | $1.01M | Sell |
126,056
-194,676
| -61% | -$1.74M | ﹤0.01% | 4417 |
|
|
2024
Q1 | $3.73M | Buy |
320,732
+36,235
| +13% | +$401K | ﹤0.01% | 3285 |
|
|
2023
Q4 | $3.18M | Buy |
284,497
+183,515
| +182% | +$1.69M | ﹤0.01% | 3297 |
|
|
2023
Q3 | $1.56M | Sell |
100,982
-22,836
| -18% | -$383K | ﹤0.01% | 3694 |
|
|
2023
Q2 | $2.35M | Sell |
123,818
-17,306
| -12% | -$304K | ﹤0.01% | 3373 |
|
|
2023
Q1 | $2.15M | Buy |
141,124
+131,005
| +1,295% | +$1.71M | ﹤0.01% | 3350 |
|
|
2022
Q4 | $129K | Sell |
10,119
-70,462
| -87% | -$634K | ﹤0.01% | 5868 |
|
|
2022
Q3 | $467K | Sell |
80,581
-9,780
| -11% | -$43K | ﹤0.01% | 4396 |
|
|
2022
Q2 | $291K | Buy |
90,361
+64,096
| +244% | +$194K | ﹤0.01% | 4647 |
|
|
2022
Q1 | $99K | Buy |
26,265
+18,989
| +261% | +$122K | ﹤0.01% | 5924 |
|
|
2021
Q4 | $95K | Buy |
7,276
+2,921
| +67% | +$46.2K | ﹤0.01% | 6357 |
|
|
2021
Q3 | $86K | Sell |
4,355
-3,157
| -42% | -$57.7K | ﹤0.01% | 5928 |
|
|
2021
Q2 | $140K | Buy |
7,512
+573
| +8% | +$12.8K | ﹤0.01% | 5618 |
|
|
2021
Q1 | $164K | Buy |
6,939
+316
| +5% | +$7.29K | ﹤0.01% | 5610 |
|
|
2020
Q4 | $162K | Buy |
6,623
+3,646
| +122% | +$93.2K | ﹤0.01% | 5369 |
|
|
2020
Q3 | $76K | Sell |
2,977
-1,423
| -32% | -$45.1K | ﹤0.01% | 5344 |
|
|
2020
Q2 | $88K | Sell |
4,400
-287
| -6% | -$6.97K | ﹤0.01% | 5400 |
|
|
2020
Q1 | $118K | Sell |
4,687
-1,506
| -24% | -$44K | ﹤0.01% | 5141 |
|
|
2019
Q4 | $163K | Buy |
+6,193
| New | +$172K | ﹤0.01% | 5731 |
|
Other funds holding ETNB
UBS Group's ETNB Position: Q4 2025 in Review
UBS Group sold out of 89bio (ETNB) in Q4 2025, closing a stake of 666,842 shares — an estimated $9.8M sold.
UBS Group first reported a position in ETNB in Q4 2019 and held it in 24 quarters. The position peaked at $9.8M in Q3 2025. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.
- UBS Group reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
- UBS Group sold 666,842 89bio shares in Q4 2025, an estimated $9.8M.
- UBS Group first reported a position in 89bio in Q4 2019 and held it in 24 quarters.
- UBS Group's 89bio position peaked at $9.8M in Q3 2025.
- 2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.
Based on UBS Group's 13F filing for Q4 2025, filed 29 Jan 2026.